These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Involvement of descending pain control system regulated by orexin receptor signaling in the induction of central post-stroke pain in mice. Matsuura W; Nakamoto K; Tokuyama S Eur J Pharmacol; 2020 May; 874():173029. PubMed ID: 32084419 [TBL] [Abstract][Full Text] [Related]
9. Timed Inhibition of Orexin System by Suvorexant Improved Sleep and Glucose Metabolism in Type 2 Diabetic db/db Mice. Tsuneki H; Kon K; Ito H; Yamazaki M; Takahara S; Toyooka N; Ishii Y; Sasahara M; Wada T; Yanagisawa M; Sakurai T; Sasaoka T Endocrinology; 2016 Nov; 157(11):4146-4157. PubMed ID: 27631554 [TBL] [Abstract][Full Text] [Related]
10. The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia. Coleman PJ; Gotter AL; Herring WJ; Winrow CJ; Renger JJ Annu Rev Pharmacol Toxicol; 2017 Jan; 57():509-533. PubMed ID: 27860547 [TBL] [Abstract][Full Text] [Related]
12. Orexin contributes to eupnea within a critical period of postnatal development. Spinieli RL; Ben Musa R; Kielhofner J; Cornelius-Green J; Cummings KJ Am J Physiol Regul Integr Comp Physiol; 2021 Oct; 321(4):R558-R571. PubMed ID: 34405704 [TBL] [Abstract][Full Text] [Related]
13. The analgesic effect of orexin-A in a murine model of chemotherapy-induced neuropathic pain. Toyama S; Shimoyama N; Shimoyama M Neuropeptides; 2017 Feb; 61():95-100. PubMed ID: 28041630 [TBL] [Abstract][Full Text] [Related]
14. Preclinical assessment of the abuse potential of the orexin receptor antagonist, suvorexant. Born S; Gauvin DV; Mukherjee S; Briscoe R Regul Toxicol Pharmacol; 2017 Jun; 86():181-192. PubMed ID: 28279667 [TBL] [Abstract][Full Text] [Related]
15. Can the Orexin Antagonist Suvorexant Preserve the Ability to Awaken to Auditory Stimuli While Improving Sleep? Drake CL; Kalmbach DA; Cheng P; Roth T; Tran KM; Cuamatzi-Castelan A; Atkinson R; Singh M; Tonnu CV; Fellman-Couture C J Clin Sleep Med; 2019 Sep; 15(9):1285-1291. PubMed ID: 31538599 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of suvorexant. Stahl SM CNS Spectr; 2016 Jun; 21(3):215-8. PubMed ID: 27322687 [TBL] [Abstract][Full Text] [Related]
17. Suvorexant: first global approval. Yang LP Drugs; 2014 Oct; 74(15):1817-22. PubMed ID: 25227290 [TBL] [Abstract][Full Text] [Related]
18. Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea. Sun H; Palcza J; Card D; Gipson A; Rosenberg R; Kryger M; Lines C; Wagner JA; Troyer MD J Clin Sleep Med; 2016 Jan; 12(1):9-17. PubMed ID: 26194728 [TBL] [Abstract][Full Text] [Related]